Title: Compositions and Methods for Inhibiting Expression of Factor VII Gene
Patent Number: 7,871,985
Filed: Dec. 10, 2008
Lead Inventor: Antonin de Fougerolles, Alnylam Pharmaceuticals
"The invention relates to a double-stranded ribonucleic acid for inhibiting the expression of the Factor VII gene," the patent's abstract states.
Title: c-Met siRNA Adenovirus Vectors Inhibit Cancer Cell Growth, Invasion, and Tumorigenicity